TKT and glioma: Besides, there are some evidence revealing that valproic acid (VPA) could promote the expression and activation of the gap junction proteins, such as connexin (Cx) 43 and 26, in glioma cells, and thereby ameliorate the bystander killing effects of the BM-MSC-TK and GCV treatment (Ryu et al., 2012).